Cutting edge: OX40 inhibits TGF-beta- and antigen-driven conversion of naive CD4 T cells into CD25+Foxp3+ T cells.

Source:http://linkedlifedata.com/resource/pubmed/id/17641007

J. Immunol. 2007 Aug 1 179 3 1427-30

Download in:

View as

General Info

PMID
17641007